NIAID Banner Logo Image


1. 45161 HIV-LS-320; PUBMED-HIV-4/19/2005

Differential Inhibition of HIV-1 and SIV Envelope-Mediated Cell Fusion by C34 Peptides Derived from the C-Terminal Heptad Repeat of gp41 from Diverse Strains of HIV-1, HIV-2, and SIV

Gustchina, E, Hummer, G, Bewley, CA, and Clore, GM

J Med Chem 2005. 48(8): 3036-3044


2. 45162 HIV-LS-320; EMBASE-HIV-4/19/2005

Suppression of Multidrug-resistant HIV-1 Reverse Transcriptase Primer Unblocking Activity by [alpha]-Phosphate-modified Thymidine Analogues

Matamoros, Tania, Deval, Jerome, Guerreiro, Catherine, Mulard, Laurence, Canard, Bruno, and Menendez-Arias, Luis

Journal of Molecular Biology 2005. In Press, Uncorrected Proof


3. 45163 HIV-LS-320; PUBMED-HIV-4/19/2005

Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection

Wei, BL, Denton, PW, O'neill, E, Luo, T, Foster, JL, and Garcia, JV

J Virol 2005. 79(9): 5705-12


4. 45164 HIV-LS-320; EMBASE-HIV-4/19/2005

Targeting HIV-1 integrase with aptamers selected against the purified RNase H domain of HIV-1 RT

Metifiot, Mathieu, Leon, Oscar, Tarrago-Litvak, Laura, Litvak, Simon, and Andreola, Marie-Line

Biochimie 2005. In Press, Uncorrected Proof


5. 45165 HIV-LS-320; PUBMED-HIV-4/19/2005

Isolation and characterisation of novel cyclotides from viola hederaceae: Solution structure and anti-HIV activity of VHL-1, A leaf-specific-expressed cyclotide

Chen, B, Colgrave, ML, Daly, NL, Rosengren, KJ, Gustafson, KR, and Craik, DJ

J Biol Chem 2005.


6. 45166 HIV-LS-320; PUBMED-HIV-4/19/2005

Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41

Liu, S, Lu, H, Zhao, Q, He, Y, Niu, J, Debnath, AK, Wu, S, and Jiang, S

Biochim Biophys Acta 2005.


7. 45167 HIV-LS-320; PUBMED-HIV-4/19/2005

Concise synthesis and antiviral activity of novel unsaturated acyclic pyrimidine nucleosides

Oh, CH, Baek, TR, and Hong, JH

Nucleosides Nucleotides Nucleic Acids 2005. 24(2): 153-60


8. 45168 HIV-LS-320; PUBMED-HIV-4/19/2005

Synthesis of (+/-)-4'-ethynyl and 4'-cyano carbocyclic analogues of stavudine (d4T)

Kumamoto, H, Haraguchi, K, Tanaka, H, Nitanda, T, Baba, M, Dutschman, GE, Cheng, YC, and Kato, K

Nucleosides Nucleotides Nucleic Acids 2005. 24(2): 73-83


9. 45169 HIV-LS-320; PUBMED-HIV-4/19/2005

HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector

Anderson, J and Akkina, R

AIDS Res Ther 2005. 2(1): 1


10. 45170 HIV-LS-320; PUBMED-HIV-4/19/2005

Deoxythreosyl Phosphonate Nucleosides as Selective Anti-HIV Agents

Wu, T, Froeyen, M, Kempeneers, V, Pannecouque, C, Wang, J, Busson, R, De, Clercq E, and Herdewijn, P

J Am Chem Soc 2005. 127(14): 5056-65


11. 45171 HIV-LS-320; PUBMED-HIV-4/19/2005

Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties

Kim, D, Wang, L, Hale, JJ, Lynch, CL, Budhu, RJ, Maccoss, M, Mills, SG, Malkowitz, L, Gould, SL, Demartino, JA, Springer, MS, Hazuda, D, Miller, M, Kessler, J, Hrin, RC, Carver, G, Carella, A, Henry, K, Lineberger, J, Schleif, WA, and Emini, EA

Bioorg Med Chem Lett 2005. 15(8): 2129-34


12. 45172 HIV-LS-320; PUBMED-HIV-4/19/2005

Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors

Harrigan, PR, Mo, T, Wynhoven, B, Hirsch, J, Brumme, Z, McKenna, P, Pattery, T, Vingerhoets, J, and Bacheler, LT

AIDS 2005. 19 (6): 549-54


13. 45173 HIV-LS-320; PUBMED-HIV-4/19/2005

Enfuvirtide resistance mutations: impact on human immunodeficiency virus envelope function, entry inhibitor sensitivity, and virus neutralization

Reeves, JD, Lee, FH, Miamidian, JL, Jabara, CB, Juntilla, MM, and Doms, RW

J Virol 2005. 79(8): 4991-9


14. 45174 HIV-LS-320; PUBMED-HIV-4/19/2005

Evaluation of an oligonucleotide ligation assay for detection of mutations in HIV-1 subtype C individuals who have high level resistance to nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors

Wallis, CL, Mahomed, I, Morris, L, Chidarikire, T, Stevens, G, Rekhviashvili, N, and Stevens, W

J Virol Methods 2005. 125(2): 99-109


15. 45175 HIV-LS-320; PUBMED-HIV-4/19/2005

Lancifodilactone F: a novel nortriterpenoid possessing a unique skeleton from Schisandra lancifolia and its anti-HIV activity

Xiao, WL, Li, RT, Li, SH, Li, XL, Sun, HD, Zheng, YT, Wang, RR, Lu, Y, Wang, C, and Zheng, QT

Org Lett 2005. 7(7): 1263-6


16. 45176 HIV-LS-320; EMBASE-HIV-4/19/2005

Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.

Uncini Manganelli, RE, Zaccaro, L, and Tomei, PE

Journal of Ethnopharmacology 2005. 98(3): 323-327


17. 45177 HIV-LS-320; EMBASE-HIV-4/19/2005

Spectrum of antiviral activity of o-(acetoxyphenyl)hept-2-ynyl sulphide (APHS)

Pereira, Candida F, Rutten, Karla, Stranska, Ruzena, Huigen, Marleen CDG, Aerts, Piet C, de Groot, Raoul J, Egberink, Herman F, Schuurman, Rob, and Nottet, Hans SLM

International Journal of Antimicrobial Agents 2005. In Press, Corrected Proof


18. 45178 HIV-LS-320; WOS-HIV-4/10/2005

The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor

Watson, C, Jenkinson, S, Kazmierski, W, and Kenakin, T

MOLECULAR PHARMACOLOGY 2005. 67(4): 1268-1282, 15


19. 45179 HIV-LS-320; WOS-HIV-4/10/2005

The conserved glycine-rich segment linking the N-terminal fusion peptide to the coiled coil of human T-cell leukemia virus type 1 transmembrane glycoprotein gp21 is a determinant of membrane fusion function

Wilson, KA, Bar, S, Maerz, AL, Alizon, M, and Poumbourios, P

JOURNAL OF VIROLOGY 2005. 79(7): 4533-4539, 7


20. 45180 HIV-LS-320; WOS-HIV-4/10/2005

Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors

Savarino, A, Cauda, R, and Cassone, A

JOURNAL OF INFECTIOUS DISEASES 2005. 191(8): 1381-1382, 2


21. 45181 HIV-LS-320; WOS-HIV-4/10/2005

Synthesis and biological evaluation of branched and conformationally restricted analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd)

Hrdlicka, PJ, Andersen, NK, Jepsen, JS, Hansen, FG, Haselmann, KF, Nielsen, C, and Wengel, J

BIOORGANIC & MEDICINAL CHEMISTRY 2005. 13(7): 2597-2621, 25


22. 45182 HIV-LS-320; WOS-HIV-4/17/2005

In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of TOPS-MODE and 2D/3D connectivity indices. 2. Purine derivatives

Vilar, S, Estrada, E, Uriarte, E, Santana, L, and Gutierrez, Y



23. 45183 HIV-LS-320; WOS-HIV-4/17/2005

Marked structural and functional heterogeneity in CXCR4: Separation of HIV-1 and SDF-I alpha responses

Sloane, AJ, Raso, V, Dimitrov, DS, Xiao, XD, Deo, S, Muljadi, N, Restuccia, D, Turville, S, Kearney, C, Broder, CC, Zoellner, H, Cunningham, AL, Bendall, L, and Lynch, GW

IMMUNOLOGY AND CELL BIOLOGY 2005. 83(2): 129-143, 15


24. 45184 HIV-LS-320; WOS-HIV-4/17/2005

Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression

Pinjon, E, Jackson, CJ, Kelly, SL, Sanglard, D, Moran, G, Coleman, DC, and Sullivan, DJ



If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2023